Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/07/06 | 1,620 | 1,644 | 1,558 | 1,610 | +5 | +0.3% | 327,500 |
2021/07/05 | 1,747 | 1,750 | 1,593 | 1,605 | -110 | -6.4% | 497,400 |
2021/07/02 | 1,946 | 1,977 | 1,677 | 1,715 | -271 | -13.6% | 605,600 |
2021/07/01 | 2,027 | 2,085 | 1,955 | 1,986 | -43 | -2.1% | 179,000 |
2021/06/30 | 2,025 | 2,075 | 1,965 | 2,029 | +2 | +0.1% | 155,900 |
2021/06/29 | 1,977 | 2,035 | 1,933 | 2,027 | +50 | +2.5% | 125,900 |
2021/06/28 | 1,946 | 2,013 | 1,923 | 1,977 | +28 | +1.4% | 129,100 |
2021/06/25 | 1,850 | 1,963 | 1,848 | 1,949 | +87 | +4.7% | 144,600 |
2021/06/24 | 1,867 | 1,980 | 1,848 | 1,862 | -5 | -0.3% | 235,000 |
2021/06/23 | 1,893 | 1,910 | 1,820 | 1,867 | +12 | +0.6% | 122,800 |
2021/06/22 | 1,793 | 1,857 | 1,769 | 1,855 | +121 | +7% | 129,400 |
2021/06/21 | 1,670 | 1,769 | 1,650 | 1,734 | -2 | -0.1% | 150,200 |
2021/06/18 | 1,818 | 1,818 | 1,720 | 1,736 | -68 | -3.8% | 210,600 |
2021/06/17 | 1,815 | 1,911 | 1,790 | 1,804 | -50 | -2.7% | 286,100 |
2021/06/16 | 1,749 | 1,869 | 1,720 | 1,854 | +113 | +6.5% | 264,200 |
2021/06/15 | 1,770 | 1,775 | 1,732 | 1,741 | -33 | -1.9% | 89,600 |
2021/06/14 | 1,724 | 1,796 | 1,678 | 1,774 | +49 | +2.8% | 177,900 |
2021/06/11 | 1,731 | 1,741 | 1,671 | 1,725 | +25 | +1.5% | 98,500 |
2021/06/10 | 1,656 | 1,716 | 1,638 | 1,700 | +6 | +0.4% | 118,900 |
2021/06/09 | 1,672 | 1,766 | 1,672 | 1,694 | +5 | +0.3% | 184,000 |
2021/06/08 | 1,689 | 1,762 | 1,664 | 1,689 | +98 | +6.2% | 357,000 |
2021/06/07 | 1,575 | 1,607 | 1,552 | 1,591 | +70 | +4.6% | 135,800 |
2021/06/04 | 1,478 | 1,523 | 1,462 | 1,521 | +20 | +1.3% | 54,200 |
2021/06/03 | 1,521 | 1,537 | 1,496 | 1,501 | -18 | -1.2% | 57,700 |
2021/06/02 | 1,551 | 1,611 | 1,511 | 1,519 | -31 | -2% | 130,800 |
2021/06/01 | 1,538 | 1,575 | 1,491 | 1,550 | +1 | +0.1% | 105,000 |
2021/05/31 | 1,555 | 1,592 | 1,541 | 1,549 | -10 | -0.6% | 81,200 |
2021/05/28 | 1,575 | 1,638 | 1,521 | 1,559 | +9 | +0.6% | 267,600 |
2021/05/27 | 1,518 | 1,574 | 1,489 | 1,550 | +50 | +3.3% | 190,400 |
2021/05/26 | 1,483 | 1,507 | 1,460 | 1,500 | +18 | +1.2% | 98,500 |
2021/05/25 | 1,417 | 1,492 | 1,400 | 1,482 | +95 | +6.8% | 182,200 |
2021/05/24 | 1,445 | 1,445 | 1,370 | 1,387 | -75 | -5.1% | 140,500 |
2021/05/21 | 1,420 | 1,480 | 1,409 | 1,462 | +55 | +3.9% | 105,200 |
2021/05/20 | 1,410 | 1,437 | 1,377 | 1,407 | -26 | -1.8% | 122,900 |
2021/05/19 | 1,344 | 1,447 | 1,343 | 1,433 | +89 | +6.6% | 229,100 |
2021/05/18 | 1,277 | 1,353 | 1,271 | 1,344 | +94 | +7.5% | 174,000 |
2021/05/17 | 1,271 | 1,311 | 1,208 | 1,250 | +2 | +0.2% | 170,900 |
2021/05/14 | 1,192 | 1,261 | 1,188 | 1,248 | +56 | +4.7% | 109,500 |
2021/05/13 | 1,211 | 1,245 | 1,156 | 1,192 | -49 | -3.9% | 224,200 |
2021/05/12 | 1,290 | 1,313 | 1,195 | 1,241 | -58 | -4.5% | 273,200 |
2021/05/11 | 1,346 | 1,359 | 1,288 | 1,299 | -73 | -5.3% | 183,300 |
2021/05/10 | 1,343 | 1,382 | 1,336 | 1,372 | +16 | +1.2% | 56,400 |
2021/05/07 | 1,336 | 1,365 | 1,315 | 1,356 | +21 | +1.6% | 43,000 |
2021/05/06 | 1,410 | 1,410 | 1,325 | 1,335 | -49 | -3.5% | 114,300 |
2021/04/30 | 1,370 | 1,392 | 1,347 | 1,384 | +23 | +1.7% | 77,900 |
2021/04/28 | 1,412 | 1,420 | 1,345 | 1,361 | -63 | -4.4% | 163,800 |
2021/04/27 | 1,443 | 1,509 | 1,410 | 1,424 | -19 | -1.3% | 197,100 |
2021/04/26 | 1,390 | 1,460 | 1,370 | 1,443 | +53 | +3.8% | 150,300 |
2021/04/23 | 1,377 | 1,479 | 1,345 | 1,390 | +16 | +1.2% | 279,300 |
2021/04/22 | 1,317 | 1,378 | 1,299 | 1,374 | +84 | +6.5% | 168,500 |
701~
750
件表示中 / 1363件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 58,800円 | - | - | 0.00% | - | 3.93倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
カイノス | 114,800円 | +6.8% | -13.8% | 2.79% | 8.80倍 | 0.77倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
キッズバイオ | 13,000円 | - | - | 0.00% | - | 7.57倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
ソレイジア | 2,600円 | +102.6% | - | 0.00% | - | 2.52倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
免疫生物 | 50,300円 | +13.4% | -4.0% | 0.00% | 40.73倍 | 3.70倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
市場注目の銘柄
チャート関連のコラム